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ABSTRACT:  
Grey-scale median of the common carotid artery intima-media complex (IM-GSM) 
characterizes the arterial wall composition and low IM-GSM is associated with an increased 
cardiovascular mortality in the elderly. We aimed to determine differences in IM-GSM 
between a cohort with cerebrovascular disease and a healthy cohort. Eighty-two healthy 
individuals (CTRL: 63.2±8.7yrs) and 96 patients with either stroke or transient ischemic 
attacks (CRVD: 68.6±9.8yrs) were studied. Common carotid artery intima-media thickness 
(cIMT) and IM-GSM obtained by ultrasound were analysed using semi-automated edge-
detection software. IM-GSM was significantly lower in CRVD than CTRL (106±30 vs 124±27 
au, p<0.001). IM-GSM was similar between the infarct and non-infarct sides in CRVD. In the 
pooled cohort of all participants, the lower the quartile of IM-GSM, the greater cIMT and 
carotid artery remodelling were. These results suggest the presence of an altered 
atherosclerotic phenotype in the intima-media complex of CVRD patients that can be 
detected by ultrasound. 
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INTRODUCTION: 
Atherosclerosis is importantly involved in the aetio-pathology of a large proportion 
of strokes. Common carotid artery intima-media thickness (cIMT) by B-mode ultrasound is a 
widely used assessment of atherosclerotic vascular risk, is a predictor for stroke incidence 
(Bots et al. 1997), and is associated with prevalence of stroke (Ebrahim et al. 1999). 
However, a greater cIMT by itself does not necessarily indicate the presence of 
atherosclerosis or an atherosclerotic process occurring within the arterial wall. In fact, the 
age-related increase in cIMT may occur without overt atherosclerosis in humans (Spence 
2006), and cIMT is mainly predicted by age and blood pressure in multiple regression 
analysis (Al-Shali et al. 2005). These issues illustrate a potential drawback of cIMT to 
evaluate atherosclerotic vascular changes and indicate a need for an assessment that better 
characterizes changes to the arterial wall.  
 
Differences in the composition of the arterial wall and plaque have been shown to 
produce variations in the ultrasound signal returned from a vessel (Goncalves et al. 2004). 
Grey scale median of the common carotid artery intima-media complex (IM-GSM) is based 
on variations in echogenicity of cIMT that have been shown to characterize the composition 
of the arterial wall. Low IM-GSM also reflects more generalized atherosclerotic vulnerability 
(Lind et al. 2007) and the lowest tertile of IM-GSM was associated with an 8-fold increase in 
CV mortality compared with the mid-tertile in an elderly male population (Wohlin et al. 
2009). Plaque echogenicity provides useful information about the vulnerability of plaques 
(e.g. stable or rupture-prone unstable plaque) (Mathiesen and Johnsen 2009) and is 
associated with increased risk of stroke (Polak et al. 1998; Gronholdt et al. 2001; Mathiesen 
et al. 2001) and cardiovascular (CV) events (Honda et al. 2004; Reiter et al. 2008). IM-GSM is 
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closely related to carotid plaque echogenicity (Lind et al. 2007), suggesting that the 
biological mechanism underlying echogenicity of arterial wall may be similar between cIMT 
and plaque. Because it is not possible to obtain histological data from the common carotid 
artery of patients, an alternative method to characterise the appearance of the arterial wall 
may therefore be useful to monitor early atherosclerotic processes in the carotid artery 
before overt plaque develops.  
 
IM-GSM may also provide a useful measurement for the evaluation of therapeutic 
interventions aimed at reducing vascular risk. Combining IM-GSM with established 
measurements, such as cIMT and vascular remodelling, has the potential to identify 
clustering of vascular biomarkers that allow early identification of pathology and improves 
patient stratification and management. It may also be useful in studying in vivo 
pathophysiology, and ‘intermediate’ biomarkers may be useful in evaluating interventions 
that target vascular disease. In this study, we set out to determine the utility of three 
ultrasound-based biomarkers of the common carotid artery: arterial wall echogenicity (IM-
GSM), arterial wall thickness (cIMT), and vascular remodelling (wall to lumen ratio; WLR). 
We took three approaches to this initial investigation of these biomarkers. First, we 
compared these biomarkers in an apparently healthy cohort with those in a cohort with 
recently diagnosed cerebrovascular disease (stroke or transient ischemic attacks; TIA). Wall 
thickness and vascular remodelling are known to vary from person to person, but the 
influence of those variations on IM-GSM is unknown. Second, we compared the biomarkers 
in the right and left carotid arteries within patients with cerebrovascular disease. This 
allowed us to compare arteries with identical ‘traditional’ risk factors. Previous studies have 
shown bilateral differences in cIMT in middle-aged and older non-lacunar cerebral infarct 
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patients (Onbas et al. 2005), but it is unknown if bilateral differences in cIMT also reflect 
differences in arterial wall composition. As part of this analysis, we also compared vascular 
biomarkers from the affected- and non-affected sides of the brain in the cerebrovascular 
disease group. Finally, we explored the associations between IM-GSM, cIMT and WLR in a 
pooled data set.  
 
MATERIALS AND METHODS: 
In total, 178 individuals (66.1±9.6yrs, 72F) participated in this study. Participants 
were allocated to the cerebrovascular disease group (CRVD: n=96, 68.6±9.8yrs, 30F) or the 
control group (CTRL: n=82, 63.2±8.7yrs, 42F). Individuals in CRVD had a stroke (n=46) or TIA 
(n=50) diagnosed within the three months before the first study visit, and were recruited 
from the daily stroke clinic and the acute stroke unit at the Royal Devon and Exeter Hospital, 
Exeter, UK. Individuals with cardioembolic, or haemorrhagic stroke/TIA were excluded. 
Individuals in the control group had no overt CV disease, cerebrovascular disease, type 2 
diabetes, hypertension, or dyslipidaemia. In the morning of the study visit, participants were 
asked to abstain from taking any medications. UK National Research Ethics Service South 
West Committee approved all study procedures and written informed consent was obtained 
from all individuals.  
 
Experimental Procedures 
Participants attended the laboratory after an overnight fast and blood samples were 
drawn before they ate a standardized meal. After resting supine for 10 min, blood pressure 
was measured using an automated oscillometric device (M5-I, Omron, Japan). 
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The carotid arteries were assessed non-invasively using a Doppler ultrasound 
machine with a high-resolution linear array transducer (SSD-5500 SV, Aloka, Japan). Subjects 
lay supine on an examination bed with the head turned ~45° away from the examined side. 
The settings of the ultrasound machine were optimised, and the time-gain compensation 
was set in the neutral position. The B-mode common carotid artery images with satisfactory 
quality were stored in the ultrasound machine, and were downloaded later for off-line 
analysis. All images were taken at the R-wave of the ECG. 
 
cIMT and IM-GSM were analyzed using semi-automated edge-detection software 
(Artery Measurement System: ver 2.02, Gothenburg, Sweden) (Liang et al. 2000). The 
software automatically identified a 10 mm-long segment (from the beginning of the bulb) of 
the near wall-lumen boundary and the far wall IMT of the common carotid artery free from 
plaques (defined as >50% increase in cIMT compared to adjacent cIMT). This automated 
analysis could be adjusted manually if the identification of borders was not appropriate. IM-
GSM was analysed using the same region of interest as cIMT. The software calculated IM-
GSM by analysing individual pixels within the region of interest on a scale from 0 (black) to 
255 (white). For calibration, the lumen was used for the reference value for black and the 
brightest area of the adventitia was used for the reference value for white. cIMT was 
defined as the height between the lumen-intima and the media-adventitia borders at the far 
wall. WLR was defined as the ratio of cIMT to the lumen diameter. For all the carotid artery 
variables, data from the right and left sides of the common carotid arteries were averaged, 
and mean values were used for statistical analysis (except for the left and right side 
comparison, and the infarct- and non-infarct side comparison in CRVD). Using the software, 
intra-observer variability for repeated assessments (20 images, at least 1 week apart) of the 
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carotid artery diameter, IMT and IM-GSM was assessed and the coefficient of variation was 
1.3% for lumen diameter, 1.4% for cIMT, and 1.2% for IM-GSM, respectively. 
 
Statistical analysis 
All data are presented as means±SD for variables with normal distribution, and 
median (interquartile range) for variables with skewed distribution. A chi-square test was 
used to examine the differences in categorical variables between CRVD and CTRL. 
Independent samples t-test for variables with normal distribution, and a Mann-Whitney U 
test for variables with skewed distribution were used to examine the differences in variables 
between CRVD and CTRL. We used a Kruskal-Wallis test to determine differences between 
the quartiles of IM-GSM that were derived from the pooled data set of all participants 
(Quartile 1, IM-GSM<96.4; Quartile 2, 96.4≤IM-GSM<112.8; Quartile 3, 112.8≤IM-
GSM<133.6; Quartile 4, 133.6≤IM-GSM). Spearman’s correlation coefficient was calculated 
to examine the associations between the quartiles of IM-GSM and carotid artery variables. 
Significance was set at p<0.05. Statistical analysis was performed using IBM SPSS Statistics 
version 21 (IBM, Armonk, NY). A post-hoc power calculation revealed that we had 99% 
power to detect a statistically significant difference in IM-GSM between CTRL and CRVD.   
 
RESULTS: 
A typical example of ultrasound images of the common carotid artery far-wall 
intima-media complex from a healthy individual (a) and stroke patient (b) is shown in Figure 
1.   
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Characteristics of CRVD and CTRL are shown in Table 1. The participants in CRVD 
were older than those in CTRL (p<0.001). There were more male participants in CRVD than 
in CTRL (p=0.007). BMI of CRVD was greater than CTRL (p<0.001). Total, LDL and HDL 
cholesterol concentrations were higher in CTRL than those of CRVD (all p<0.001). However, 
total and LDL cholesterol concentrations were not different between the groups after 
controlling for the statin treatment (data not shown). Lumen diameter, mean cIMT, and 
maximum cIMT were greater in CRVD than CTRL (all p<0.001) and IM-GSM was significantly 
lower in CRVD than CTRL (p<0.001). These differences were independent of age and sex.  
 
Carotid artery variables in CRVD divided into the right and left sides are shown in 
Table 2-1. The right side lumen diameter was greater than the left side (p=0.003). Mean 
IMT, maximum IMT, WLR, and IM-GSM were all similar between the sides in this group. 
Carotid artery variables in CRVD divided into the infarct- and non-infarct sides are shown in 
Table 2-2. All the variables were similar between the infarct and non-infarct side in this 
group.  
 
Table 3 shows the pooled data set of characteristics derived from all study 
participants, divided by the quartiles of IM-GSM. The participants in lower IM-GSM quartiles 
were older (p=0.014). There was a significant increase in BMI with the reduction in IM-GSM 
(p=0.004). Total (p=0.006) and LDL cholesterol (p=0.014) concentration was significantly 
greater with increased IM-GSM, but this was not the case after controlling for statin 
treatment (data not shown).  Systolic blood pressure was significantly higher with the lower 
IM-GSM (p=0.036), but this association did not remain after controlling for anti-
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hypertensive treatment (data not shown). The number of individuals with a stroke/TIA, 
hypertension and dyslipidaemia was higher with the lower IM-GSM (all p<0.001). 
 
Carotid artery variables derived from the pooled data set of all study participants 
divided by the quartiles of IM-GSM are shown in Table 4. There was a significant increase in 
mean cIMT, maximum cIMT  and WLR with the reduction in IM-GSM (all p<0.001). These 
associations were independent of age, BMI, total and LDL cholesterol, systolic blood 
pressure, and medical history (stroke/TIA, hypertension and dyslipidaemia). There was also 
a significant inverse association between IM-GSM and mean cIMT (ρ=-0.508), maximum 
cIMT (ρ=-0.435) and WLR (ρ=-0.445, all p<0.001: Figure 2). Lumen diameter was similar 
among the quartiles.   
 
DISCUSSION: 
The salient findings of this study are as follows. First, IM-GSM was lower in CRVD 
compared with CTRL. Second, there was no bilateral difference in IM-GSM between the 
right and left sides or between the infarct and the non-infarct sides in CRVD. Third, lower 
IM-GSM was associated with greater cIMT and WLR in the pooled data set. These results 
show that IM-GSM is lower in the presence of stroke/TIA, suggesting the presence of an 
altered atherosclerotic phenotype in these patients. The results also suggest that this 
altered phenotype may be systemic in CRVD patients, rather than restricted to the infarct 
side. The inverse association observed between cIMT, WLR and IM-GSM indicates that these 
alterations in the arterial wall may be linked, raising a possibility of common mechanistic 
involvement and clustering of vascular risk factors. To our knowledge, this is the first study 
to show differences in IM-GSM between CRVD and healthy cohorts, demonstrating the 
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potential for IM-GSM to provide additional and relevant information about the status of the 
arterial wall during a routine ultrasound examination.   
 
IM-GSM between the cerebrovascular disease and control groups 
IM-GSM was lower in CRVD than CTRL in this study, indicating a worse phenotype. 
The only comparable data are from sub-group analysis (2% of 942 participants) of an elderly 
cohort where IM-GSM of stroke sufferers was also lower than that of stroke-free subjects 
(Andersson et al. 2009). The majority of data derived from GSM has been from studies of 
carotid plaque. Echolucent plaque on the B-mode ultrasound image has been reported to be 
indicative of histological features of vulnerability, such as high lipid and macrophage content 
(Gronholdt 1999), intra-plaque haemorrhage (Gronholdt et al. 2002) and  neovascularization 
(Coli et al. 2008). There is also an association between echolucent plaque and increased risk 
for ischemic stroke (Polak et al. 1998; Gronholdt et al. 2001; Mathiesen et al. 2001). Given 
the close relationship between plaque echogenicity and IM-GSM (Lind et al. 2007), it is 
plausible that reduced IM-GSM observed in CRVD could be explained by vascular changes 
similar to those of plaque. With an ability to make serial measurements, IM-GSM has the 
potential to monitor changes in the status of the arterial wall over time.       
 
IM-GSM between the right and left carotid arteries, and the infarct and non-infarct sides 
in the cerebrovascular disease group 
Onbas et al (2005) showed that cIMT on the infarct side was greater than that of the 
non-infarct side in non-lacunar cerebral infarct patients (Onbas et al. 2005). Rodriguez 
Hernandez et al (2003) have also shown that there was a relationship between cIMT and the 
infarct side in non-lacunar stroke patients in a population-based stroke registry. These 
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findings imply an association between the infarct side of the brain and atherosclerotic 
vascular changes that could be detected by IM-GSM. However, in our dataset, IM-GSM was 
similar between the right and left sides, and also between the infarct and non-infarct sides 
in CRVD. This suggests that atherosclerotic vascular changes may progress systemically in 
CRVD. Our cIMT data also show that both mean and maximum cIMT were similar between 
the right and left sides, and between the infarct and non-infarct sides. A potential reason for 
this disparity between the previous studies (Rodriguez Hernandez et al. 2003; Onbas et al. 
2005) and ours is that we included both lacunar (n=42) and non-lacunar (n=54) stroke/TIA 
patients. However, neither patient group in our study showed a significant difference in IM-
GSM between the infarct and non-infarct sides when analysed separately (lacunar, 
104.9±27.7 vs 109.5±34.7au; non-lacunar, 103.7±23.1 vs 105.3±28.5au), in agreement with 
our principal finding.       
 
Associations between carotid artery structure and IM-GSM 
Although our study design does not allow us to establish a cause-and-effect 
relationship between wall thickness, vascular remodelling and IM-GSM, this is, to our 
knowledge, the first study to suggest that vascular remodelling modulates pre-clinical 
atherosclerosis in vivo. An inverse association between cIMT and IM-GSM has previously 
been reported in a population of 70 year-olds (Andersson et al. 2009) and in a middle-aged 
and older population with low CV risk but increased cIMT (Peters et al. 2012). Consistent 
with these findings, our data also showed an inverse association between cIMT and the 
quartiles of IM-GSM. We also showed an inverse association between WLR and the quartiles 
of IM-GSM, extending our understanding of the association between carotid artery 
structure and IM-GSM. Specifically, WLR, the lumen diameter-corrected wall thickness 
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which serves as a marker of vascular remodelling (Schiffrin 2004), showed an inverse 
association with IM-GSM. This indicates that concentric remodelling (increased cIMT relative 
to lumen diameter) exhibits more atherosclerotic vascular changes and eccentric 
remodelling (reduced cIMT relative to lumen diameter) exhibits less atherosclerotic vascular 
change. Thus, we speculate that IM-GSM is influenced by both cIMT and remodelling that 
alters lumen diameter, such that arterial walls with similar cIMT will have different IM-GSM 
if lumen diameter is different.    
 
Clinical implications 
An advantage of IM-GSM is that it can be performed in individuals without overt 
plaque, and can evaluate vascular changes at different stages of the atherosclerotic CV 
disease continuum. This could extend the use of existing ultrasound assessment to identify 
individuals at risk of atherosclerosis early in the aetio-pathology of CV disease (Wohlin et al. 
2009) and enable early management and intervention. In particular, this could be helpful in 
borderline risk individuals where the use of classical risk stratification tools, such as the 
Framingham risk scale, could potentially over- or underestimate CV disease risk. 
 
Because we included a large number of patients and an older control group, we 
expected to find carotid plaque in a proportion of participants. At least one carotid artery 
plaque was found in 80% of CRVD and 50% of CTRL participants. Whereas IM-GSM is closely 
related to carotid plaque echogenicity (Lind et al. 2007), which is associated with increased 
risk of stroke (Polak et al. 1998; Gronholdt et al. 2001; Mathiesen et al. 2001), it is currently 
unknown whether IM-GSM predicts future stroke events independently of the presence of 
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carotid plaque and/or the degree of echogenicity of carotid plaque.  A longitudinal study will 
be necessary to answer this question.   
 
Consistent with previous studies (Andersson et al. 2009; Peters et al. 2012), our IM-
GSM data correlated with BMI. This raises the possibility that IM-GSM might be amenable to 
beneficial modification (increased IM-GSM) by controlling BMI and related CV risk factors. A 
3-year treatment with a β-blocker showed a significant increase in plaque echogenicity 
(Ostling et al. 2011). A post-hoc analysis of the METEOR study has also suggested a 
beneficial effect of 2-year rosuvastatin treatment on IM-GSM in individuals with low IM-
GSM at baseline (Lind et al. 2012). Additional studies are essential to establish the effect of 
CV risk factor modification on IM-GSM. 
 
Limitations 
First, although histological information of IM-GSM could be of benefit, it is not 
possible to obtain histological samples for IM-GSM from living persons without an indication 
for carotid endarterectomy. Nor is it possible to obtain serial histological samples to 
determine if changes in carotid IM-GSM are explained by compositional changes to the 
arterial wall. However, as plaque echogenicity reflects histological plaque composition 
(Goncalves et al. 2004), IM-GSM may also be determined by the properties of the arterial 
wall. IM-GSM also has some advantages over histology as serial measurements are possible 
that allow changes in IM-GSM over time to be monitored. Accumulating evidence suggests 
that characterisation of the ultrasound appearance of vessels may have clinical utility, 
although we acknowledge that additional insight from histological studies and virtual 
histology would be informative. Second, differences in gain settings between individuals 
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could influence IM-GSM, but Peters et al (2013) report that variability in gain setting did not 
change the direction as well as magnitude of the relationship between echogenicity, CV risk 
factors and the observed rates of changes in echogenicity (Peters et al. 2013). We also use a 
calibration procedure to standardise IM-GSM analysis that has been shown to reduce 
variability in gain settings (Peters et al. 2013). Third, differences in IM-GSM between studies 
may be explained by the use of different machines, but our data were obtained using the 
same ultrasound machine for all participants. We acknowledge that there will be a need for 
standardization on the IM-GSM assessment before implementing it as a diagnostic 
parameter. This may include the development of software for IM-GSM that could be 
incorporated into commercial ultrasound systems, and of a phantom to calibrate IM-GSM B-
mode images. Finally, an inherent limitation that applies to all ultrasound vascular 
assessment is the influence of the tissue composition between the ultrasound probe and 
target. This could have influenced our data because there was an inverse association 
between IM-GSM and BMI in this study. However, the observed associations between IM-
GSM and carotid artery biomarkers were independent of BMI. Thus, we think that IM-GSM 
scores obtained from the intima-media more closely reflect changes in the composition of 
the arterial wall, and not the tissue composition between the probe and the artery.          
 
CONCLUSIONS: 
IM-GSM was lower in stroke/TIA patients compared with control, but there was no 
bilateral difference in IM-GSM in these patients. We also found an inverse association 
between wall thickness, vascular remodelling and IM-GSM. These results suggest the 
presence of an altered atherosclerotic phenotype in stroke/TIA patients that may be 
systemic, rather than restricted to the infarct side. The inverse association between wall 
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thickness, vascular remodelling and IM-GSM suggests that alterations in the composition of 
the carotid artery wall may be influenced by the extent of arterial remodelling, and that 
these vascular risk factors cluster in the carotid artery. IM-GSM may thus have a potential to 
provide additional and relevant information about the status of the arterial wall during a 
routine ultrasound examination in individuals with cerebrovascular disease.  
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FIGURE CAPTIONS LIST: 
Figure 1. Example of ultrasound images of the carotid artery far-wall intima-media complex 
from a healthy individual (a) and stroke patient (b). A similar ultrasound gain setting was 
used for both acquisitions. Darker cIMT produces lower scores and is associated with 
increased vascular risk. cIMT was similar between individuals (0.928 mm and 0.939 mm) but 
IM-GSM was lower in the stroke patients (91 au) than the healthy  participants (144 au).  
 
Figure 2. Carotid artery lumen diameter (top left), mean intima-media thickness (top right), 
maximum intima-media thickness (bottom left) and wall-to-lumen ratio (bottom right) data 
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divided by the quartiles of IM-GSM in the pooled data set of all study participants. Data are 
median (95% confidence interval). 
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Table 1. Selected characteristics, medical history and carotid artery biomarkers of the study 
participants.  
 
 Control  
Cerebrovascular 
Disease  
p 
Age, yrs 63.2±8.7 68.6±9.8 <0.001 
Sex, M/F 40/42 66/30 0.007 
Smoking, n 4 7 0.505 
BMI, kg/m2 25.5±3.6 28.0±4.0 <0.001 
Total CHOL, mmol/l 5.70 (5.00–6.30) 3.90 (3.38–4.60) <0.001 
LDL CHOL, mmol/l 3.35 (2.88–3.91) 1.82 (1.49–2.44) <0.001 
HDL CHOL, mmol/l 1.68 (1.34–2.00) 1.35 (1.11–1.71) <0.001 
Triglycerides, mmol/l 1.03 (0.83–1.49) 1.05 (0.83–1.50) 0.897 
Glucose, mmol/l 5.00 (4.80–5.50) 5.20 (4.73–5.68) 0.256 
Systolic BP, mmHg 138.5±18.8 141.9±16.8 0.207 
Diastolic BP, mmHg 79.2±9.0 78.9±8.6 0.820 
Type 2 Diabetes, n 0 10 0.003 
Hypertension, n 0 70 <0.001 
CAD, n 0 12 0.001 
PAD, n 0 1 0.354 
Dyslipidaemia, n 0 89 <0.001 
Lumen diameter, mm 5.68±0.61 6.08±0.66 <0.001 
cIMT mean, mm 0.76 (0.69–0.87) 0.87 (0.80–0.95) <0.001 
cIMT maximum, mm 0.90 (0.78–1.03) 1.02 (0.93–1.17) <0.001 
WLR, au 0.137 (0.120–0.156) 0.143 (0.129-0.163) 0.087 
Carotid plaque, n 41 77 <0.001 
IM-GSM, au 123.6±27.4 105.8±24.3    <0.001 
 
Data are shown as means±SD or median (interquartile range). BMI, body mass index; CHOL, 
cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein; BP, blood pressure; 
CAD, coronary artery disease; PAD, peripheral artery disease; cIMT, common carotid artery 
intima-media thickness; WLR, wall-to-lumen ratio; Carotid plaque, number of individuals 
with the presence of at least one carotid plaque; IM-GSM, grey scale median of the carotid 
artery intima-media complex. 
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Table 2-1. Carotid artery biomarkers of the right and left sides in CRVD. 
 
 Right side Left side p 
Lumen diameter, mm 6.11±0.70 5.97±0.66 0.003 
IMT mean, mm 0.89±0.17 0.88±0.17 0.875 
IMT maximum, mm 1.05±0.21 1.05±0.19 0.807 
WLR, au 0.147±0.032 0.149±0.029 0.408 
IM-GSM, au 106.2±29.4 105.1±27.4 0.722 
 
 
Table 2-2. Carotid artery biomarkers of the infarct- and non-infarct sides in CVRD. 
 
 Infarct side Non-infarct side p 
Lumen diameter, mm 6.01±0.72 6.07±0.65 0.214 
IMT mean, mm 0.88±0.16 0.89±0.18 0.246 
IMT maximum, mm 1.04±0.19 1.05±0.21 0.467 
WLR, au 0.147±0.028 0.149±0.033 0.524 
IM-GSM, au 105.1±27.9 106.2±28.8 0.708 
 
Data are shown as means±SD. Abbreviations as Table 1. 
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Table 3. Selected characteristics and medical history of the all participants derived from the pooled data set divided by the quartiles of IM-
GSM. 
 Quartile1 (<96.4) 
Quartile2 (96.4-
112.7) 
Quartile3 (112.8-133.5) Quartile4 (≥133.6) P 
Age, yrs 68.5 (63.3–76.3) 65.0 (61.5–74.0) 63.0 (55.5–68.5) 65.0 (60.0–69.0) 0.014 
Sex, M/F 28/16 30/15 24/21 24/20 0.488 
Smoking, n 1 4 4 2 0.475 
BMI, kg/m2 28.0 (26.1–31.0) 26.5 (24.0–30.1) 25.4 (23.6–28.0) 25.4 (22.9–29.2) 0.004 
Total CHOL, mmol/l 4.60 (3.43–5.73) 4.15 (3.50–4.88) 4.90 (4.30–5.65) 5.30 (4.20–6.10) 0.006 
LDL CHOL, mmol/l 2.57 (1.69–3.69) 1.89 (1.54–3.00) 2.77 (2.30–3.33) 3.15 (2.30–3.86) 0.014 
HDL CHOL, mmol/l 1.50 (1.13–1.83) 1.37 (1.18–1.80) 1.54 (1.28–1.92) 1.56 (1.21–1.94) 0.493 
Triglycerides, mmol/l 1.26 (0.94–1.57) 1.06 (0.67–1.41) 1.07 (0.85–1.53) 0.95 (0.84–1.27) 0.169 
Glucose, mmol/l 5.40 (4.80–5.80) 5.20 (4.80–5.55) 5.00 (4.70–5.55) 5.00 (4.70–5.50) 0.178 
Systolic BP, mmHg 142.8 (134.0-159.0) 141.9 (131.9–148.9) 133.3 (122.5–143.3) 140.7 (126.7–153.6) 0.036 
Diastolic BP, mmHg 78.2 (72.6-88.3) 78.4 (72.1-83.2) 77.3 (73.0-84.4) 81.2 (71.3-87.3) 0.546 
Stroke / TIA, n 32 31 18 15 <0.001 
Type 2 Diabetes, n 6 1 1 2 0.061 
Hypertension, n 28 22 10 10 <0.001 
CAD, n 3 5 3 1 0.429 
PAD, n 0 1 0 0 0.396 
Dyslipidaemia, n 29 29 18 13 0.001 
IM-GSM, au 79.8 (72.9-91.6) 102.5 (98.5-109.3) 121.0 (117-129.5) 148.6 (140.0-158.3) <0.001 
 
Data are shown as median (interquartile range). Abbreviations as Table 1.      
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Table 4. Carotid artery biomarkers of all participants derived from the pooled data set divided by the quartiles of IM-GSM. 
 
 Quartile1 (<96.4) 
Quartile2 (96.4-
112.7) 
Quartile3 (112.8-133.5) Quartile4 (≥133.6) P 
Lumen diameter, mm 5.92 (5.56-6.24) 6.01 (5.61-6.50) 5.73 (5.21-6.23) 5.84 (5.44-6.20) 0.153 
IMT mean, mm 0.93 (0.84-1.05) 0.87 (0.78-0.99) 0.75 (0.69-0.86) 0.74 (0.64-0.85) <0.001 
IMT maximum, mm 1.06 (0.98-1.20) 1.01 (0.92-1.17) 0.90 (0.80-1.04) 0.88 (0.76-1.02) <0.001 
WLR, au 0.161 (0.141-0.180) 0.146 (0.125-0.164) 0.134 (0.122-0.146) 0.128 (0.112-0.143) <0.001 
 
Data are shown as median (interquartile range). Abbreviations as Table 1.         
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Figure 1.  
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Figure 2. 
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